Parkman Healthcare Partners’s RxSight RXST Stock Holding History

Parkman Healthcare Partners’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Sell	249,989 -101,666	-29%	-$844K	0.16%	81
2025 Q4	$3.66M	Sell	351,655 -29,058	-8%	-$292K	0.35%	74
2025 Q3	$3.42M	Sell	380,713 -253,161	-40%	-$2.22M	0.36%	72
2025 Q2	$8.24M	Buy	633,874 +2,636	+0.4%	+$39.6K	0.95%	38
2025 Q1	$15.9M	Buy	631,238 +330,540	+110%	+$9.82M	1.89%	18
2024 Q4	$10.3M	Buy	300,698 +116,378	+63%	+$5.25M	1.38%	27
2024 Q3	$9.11M	Sell	184,320 -112,419	-38%	-$5.76M	1.16%	31
2024 Q2	$17.9M	Sell	296,739 -115,693	-28%	-$6.61M	2.39%	9
2024 Q1	$21.3M	Sell	412,432 -100,600	-20%	-$4.94M	2.61%	9
2023 Q4	$20.7M	Buy	513,032 +131,701	+35%	+$3.86M	2.91%	8
2023 Q3	$10.6M	Sell	381,331 -117,300	-24%	-$3.5M	1.95%	11
2023 Q2	$14.4M	Buy	498,631 +70,838	+17%	+$1.58M	2.49%	12
2023 Q1	$7.14M	Buy	427,793 +251,372	+142%	+$3.55M	1.55%	27
2022 Q4	$2.24M	Buy	176,421 +9,660	+6%	+$117K	0.6%	54
2022 Q3	$2M	Buy	166,761 +51,761	+45%	+$711K	0.57%	55
2022 Q2	$1.62M	Buy	+115,000	New	+$1.52M	0.6%	47

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Parkman Healthcare Partners's RXST Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its RxSight (RXST) stake by 29% in Q1 2026, selling an estimated $844K and leaving 249,989 shares worth $1.54M. The position accounts for 0.16% of the portfolio, ranked #81.

Parkman Healthcare Partners first reported a position in RXST in Q2 2022 and has held it in 16 quarters since. The position peaked at $21.3M in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Parkman Healthcare Partners held 249,989 shares of RxSight worth $1.54M as of Q1 2026.
Parkman Healthcare Partners sold 101,666 RxSight shares in Q1 2026, an estimated $844K.
RxSight made up 0.16% of Parkman Healthcare Partners's portfolio in Q1 2026, its #81 holding.
Parkman Healthcare Partners first reported a position in RxSight in Q2 2022 and has held it in 16 quarters since.
Parkman Healthcare Partners's RxSight position peaked at $21.3M in Q1 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.